These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

478 related items for PubMed ID: 6144329

  • 21. Regulation of c-Fos and NGF1-A by antidepressant treatments.
    Morinobu S, Strausbaugh H, Terwilliger R, Duman RS.
    Synapse; 1997 Apr; 25(4):313-20. PubMed ID: 9097389
    [Abstract] [Full Text] [Related]

  • 22. [Biochemical effects of electroconvulsotherapy].
    Benkelfat C.
    Encephale; 1988 Apr; 14(4):273-81. PubMed ID: 2848680
    [Abstract] [Full Text] [Related]

  • 23. Long-term effect of antidepressant drugs and electroconvulsive shock on brain alpha 1-adrenoceptors following destruction of noradrenergic or serotonergic nerve terminals.
    Nowak G, Przegaliński E.
    Pol J Pharmacol Pharm; 1988 Apr; 40(4):393-400. PubMed ID: 2851781
    [Abstract] [Full Text] [Related]

  • 24. Effects of electroconvulsive shock on monoaminergic systems in the rat brain. Thesis.
    Wielosz M.
    Pol J Pharmacol Pharm; 1983 Apr; 35(2):127-30. PubMed ID: 6684770
    [Abstract] [Full Text] [Related]

  • 25. Electroconvulsive shock and reserpine: effects on beta-adrenergic receptors in rat brain.
    Kellar KJ, Cascio CS, Bergstrom DA, Butler JA, Iadarola P.
    J Neurochem; 1981 Oct; 37(4):830-6. PubMed ID: 6275033
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Drug-induced alterations in neurotransmitter receptor binding and function.
    Enna SJ, Ferkany JW, Strong R.
    Adv Biochem Psychopharmacol; 1980 Oct; 21():253-63. PubMed ID: 6246740
    [No Abstract] [Full Text] [Related]

  • 28. Decreased density of beta-adrenergic and muscarinic cholinergic receptor sites in the vasa nervorum of aged rats.
    Zaccheo D, De Michele M, Mancini M, Amenta F.
    Mech Ageing Dev; 1991 Nov 01; 60(3):255-65. PubMed ID: 1661357
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Changes in sensitivity of release modulating dopamine autoreceptors after chronic treatment with haloperidol.
    Nowak JZ, Arbilla S, Galzin AM, Langer SZ.
    J Pharmacol Exp Ther; 1983 Aug 01; 226(2):558-64. PubMed ID: 6875865
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Amitriptylinoxide: receptor-binding profile compared with other antidepressant drugs.
    Borbe HO, Zierenberg O.
    Pharmacopsychiatry; 1985 Sep 01; 18(5):314-9. PubMed ID: 2996040
    [Abstract] [Full Text] [Related]

  • 38. Effect of thyroid status on beta-adrenoreceptors and muscarinic receptors in the rat lung.
    Baker SP.
    J Auton Pharmacol; 1981 Sep 01; 1(4):269-77. PubMed ID: 6279669
    [Abstract] [Full Text] [Related]

  • 39. Influence of repeated administration of desmethylimipramine on beta adrenergic and muscarinic cholinergic receptors and 45Ca++ binding to sarcoplasmic reticulum in the rat heart.
    Nomura Y, Kajiyama H, Oki K.
    J Pharmacol Exp Ther; 1982 Dec 01; 223(3):834-40. PubMed ID: 6292402
    [No Abstract] [Full Text] [Related]

  • 40. Neurochemical mechanisms of action of ECS: evidence from in vivo studies.
    Newman ME, Gur E, Shapira B, Lerer B.
    J ECT; 1998 Sep 01; 14(3):153-71. PubMed ID: 9773355
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.